Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species.
about
A novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis in THP-1 transfectantsUsing Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish InfectionRetention and loss of RNA interference pathways in trypanosomatid protozoansLeishmania infantum Asparagine Synthetase A Is Dispensable for Parasites Survival and InfectivityContribution of electron and confocal microscopy in the study of Leishmania-macrophage interactions.9- O-acetylated sialic acids enhance entry of virulent Leishmania donovani promastigotes into macrophages.Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection.Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors.Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccinesProteophosphoglycan confers resistance of Leishmania major to midgut digestive enzymes induced by blood feeding in vector sand flies.Secretory pathway of trypanosomatid parasites.Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viabilityLeishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependentTrichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cellsIdentification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategiesLeishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular trapsLeishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection.Protozomics: trypanosomatid parasite genetics comes of age.Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensisPathogen-derived oligosaccharides improve innate immune response to intracellular parasite infectionPutting the Leishmania genome to work: functional genomics by transposon trapping and expression profiling.The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts.The genetic toolbox for Leishmania parasitesDifferential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells.Heme oxygenase-1 promotes the persistence of Leishmania chagasi infectionComparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania majorRecent developments in the molecular, biochemical and functional characterization of GPI8 and the GPI-anchoring mechanism [review].Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycansComparative genomics: from genotype to disease phenotype in the leishmaniases.Functional paradox in host-pathogen interaction dictates the fate of parasites.Modulation of dendritic cell function by Leishmania parasitesLeishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functionsLeishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hostsCharacterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major.Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan.Shuttle mutagenesis and targeted disruption of a telomere-located essential gene of Leishmania.
P2860
Q24800614-998928BF-94B9-4120-BFD8-73269B447B64Q26739973-958750FC-867F-47A7-B092-FA85E94F73EAQ28475957-C3EB152C-F883-4840-B85D-6F47AD27640AQ28552512-C83E48A6-1D8F-4CB3-8C0D-D13197FF1E06Q31125463-27A53031-4AC3-4220-91BC-44885BBFE0F4Q33392744-1B754227-F2AC-4770-BAD7-77E1CD96AF23Q33402474-2485165F-7C15-461B-9C5C-6615040B62BFQ33525007-76A0E7E9-9AC2-4C6B-9BF8-548F890320EFQ33566856-E32A467C-D9BA-4E1C-819B-EDC5245BED64Q33870163-B03E9B54-345B-4E20-9CF4-631B79E3BDFEQ33938758-1CD4EA45-F71A-4F6C-BE86-7F5EF0FD5DCFQ33969495-D3EB4EBF-8C90-4106-9E85-0A15CE8D7A9DQ34090960-C1D0D01F-C928-4175-850D-76FF8FA354E0Q34127073-981EA129-D590-4FCD-BC7A-498B1A886FB1Q34144011-EDD10631-210B-42BA-9A4C-BD4727D122C1Q34147052-76F2150D-D126-4452-B908-E1A5DD790BC4Q34257759-B607FB2B-B863-4D4F-97BE-138D51133F42Q34347500-76D64A40-D5D2-4178-9E22-8EB72B5FA4A1Q34974266-AA3A423D-7EFB-4023-9795-2D91C43F9064Q34992273-04363957-0313-4189-9CB5-E110106901CBQ35011520-A6738BA3-9E72-4B1C-845C-7FA0145FA8BAQ35037654-4026DEB8-1314-476F-B846-6FBE7731C2D8Q35165095-8168CC5D-595B-45B4-974C-A71CF6924095Q35167881-D4062E55-C230-4A71-85F2-91073A799B80Q35212975-7AC93E2F-4D04-4B87-A272-6566F665D9FEQ35234866-F95BDCAE-FA7C-4B7F-B998-114AAE36EB60Q35623857-6411B0FC-B8A9-4002-A47E-A6426D01B20DQ35859111-5A4D15BB-075D-471F-B84A-223EBA607673Q35903321-66FFE352-DBDD-428D-A68D-6C88ACF2CA96Q35947298-987DDB89-82D8-4EE5-83DB-B7D5B8252626Q36511643-10BFDA89-3073-4F9E-B7EA-2D8CD365434AQ36860461-3DEE3B44-5ED5-4C17-A152-BA11B6BD8600Q36889371-290414CE-5A72-4978-AFF1-27F7E4DD0AB1Q36903844-EDFFC7EF-AEE4-4538-A3FE-6F3C7FC453ADQ37091427-06EB8E76-2A7C-46BA-8EBD-8347CFB47BE3Q37274842-717D9512-CDB4-4452-B9C1-5FBC4EC2FA70Q37288178-CC38A1B5-C34F-47FC-87B7-210E1765ED8DQ37624352-2B097253-EFBE-4526-A576-F1C62F3CBC9EQ38004492-8B512309-93CD-4DF3-B126-1B1435AF0A3EQ40196519-33F218BA-DE44-42C7-964C-02DE8911A99E
P2860
Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@ast
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@en
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@nl
type
label
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@ast
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@en
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@nl
prefLabel
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@ast
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@en
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@nl
P1476
Is lipophosphoglycan a virulen ...... ty between Leishmania species.
@en
P2093
P304
P356
10.1016/S1471-4922(01)01895-5
P577
2001-05-01T00:00:00Z